These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37167008)

  • 41. Sample size re-estimation for clinical trials with longitudinal negative binomial counts including time trends.
    Asendorf T; Henderson R; Schmidli H; Friede T
    Stat Med; 2019 Apr; 38(9):1503-1528. PubMed ID: 30575061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A sample size calculator for
    Kim H; Ionides E; Almirall D
    SIAM Undergrad Res Online; 2016; 9():229-250. PubMed ID: 34676274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimization of behavioral dynamic treatment regimens based on the sequential, multiple assignment, randomized trial (SMART).
    Collins LM; Nahum-Shani I; Almirall D
    Clin Trials; 2014 Aug; 11(4):426-434. PubMed ID: 24902922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SMART designs in cancer research: Past, present, and future.
    Kidwell KM
    Clin Trials; 2014 Aug; 11(4):445-456. PubMed ID: 24733671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesizing independent stagewise trials for optimal dynamic treatment regimes.
    Chen Y; Wang Y; Zeng D
    Stat Med; 2020 Dec; 39(28):4107-4119. PubMed ID: 32804414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sample size calculation in clinical trials with two co-primary endpoints including overdispersed count and continuous outcomes.
    Homma G; Yoshida T
    Pharm Stat; 2024; 23(1):46-59. PubMed ID: 38267827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bayesian sample size calculations for comparing two strategies in SMART studies.
    Turchetta A; Moodie EEM; Stephens DA; Lambert SD
    Biometrics; 2023 Sep; 79(3):2489-2502. PubMed ID: 36511434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamic treatment regimes: practical design considerations.
    Lavori PW; Dawson R
    Clin Trials; 2004 Feb; 1(1):9-20. PubMed ID: 16281458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Authors' redress on 'robustness of methods for blinded sample size re-estimation with overdispersed count data'.
    Cook RJ
    Stat Med; 2013 Sep; 32(22):3955-7. PubMed ID: 24030889
    [No Abstract]   [Full Text] [Related]  

  • 50. Interim monitoring of sequential multiple assignment randomized trials using partial information.
    Manschot C; Laber E; Davidian M
    Biometrics; 2023 Dec; 79(4):2881-2894. PubMed ID: 36896962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Information-based sample size re-estimation in group sequential design for longitudinal trials.
    Zhou J; Adewale A; Shentu Y; Liu J; Anderson K
    Stat Med; 2014 Sep; 33(22):3801-14. PubMed ID: 24797715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blinded and unblinded internal pilot study designs for clinical trials with count data.
    Schneider S; Schmidli H; Friede T
    Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time-varying SMART design and data analysis methods for evaluating adaptive intervention effects.
    Dai T; Shete S
    BMC Med Res Methodol; 2016 Aug; 16(1):112. PubMed ID: 27578254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequential multiple assignment randomized trial studies should report all key components: a systematic review.
    Bigirumurame T; Uwimpuhwe G; Wason J
    J Clin Epidemiol; 2022 Feb; 142():152-160. PubMed ID: 34763037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Introduction to SMART designs for the development of adaptive interventions: with application to weight loss research.
    Almirall D; Nahum-Shani I; Sherwood NE; Murphy SA
    Transl Behav Med; 2014 Sep; 4(3):260-74. PubMed ID: 25264466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes.
    Maleyeff L; Wang R; Haneuse S; Li F
    Stat Med; 2023 Nov; 42(27):5054-5083. PubMed ID: 37974475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A gate-keeping test for selecting adaptive interventions under general designs of sequential multiple assignment randomized trials.
    Zhong X; Cheng B; Qian M; Cheung YK
    Contemp Clin Trials; 2019 Oct; 85():105830. PubMed ID: 31470107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Get SMART - Understanding Sequential Multiple Assignment Randomized Trials.
    Kim HM
    NEJM Evid; 2023 Apr; 2(4):EVIDe2300031. PubMed ID: 38320015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A "SMART" design for building individualized treatment sequences.
    Lei H; Nahum-Shani I; Lynch K; Oslin D; Murphy SA
    Annu Rev Clin Psychol; 2012; 8():21-48. PubMed ID: 22224838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blinded sample size re-estimation for comparing over-dispersed count data incorporating follow-up lengths.
    Igeta M; Matsui S
    Stat Med; 2022 Dec; 41(29):5622-5644. PubMed ID: 36148560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.